Allianz Asset Management GmbH Boosts Stock Position in Pediatrix Medical Group, Inc. $MD

Allianz Asset Management GmbH raised its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 159.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 61,412 shares of the company’s stock after acquiring an additional 37,712 shares during the period. Allianz Asset Management GmbH owned approximately 0.07% of Pediatrix Medical Group worth $881,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its stake in Pediatrix Medical Group by 219.5% during the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock valued at $37,000 after acquiring an additional 1,765 shares during the last quarter. Marshall & Sullivan Inc. WA purchased a new stake in Pediatrix Medical Group during the 2nd quarter valued at approximately $41,000. AlphaQuest LLC raised its stake in Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock valued at $85,000 after acquiring an additional 811 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in Pediatrix Medical Group during the 1st quarter valued at approximately $159,000. Finally, Optimize Financial Inc purchased a new stake in Pediatrix Medical Group during the 1st quarter valued at approximately $167,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have commented on MD. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Pediatrix Medical Group in a research note on Saturday. Wall Street Zen raised Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 4th. Zacks Research lowered Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 7th. UBS Group upped their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a report on Thursday, August 14th. Finally, Leerink Partners upped their price objective on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Two analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average target price of $16.93.

Pediatrix Medical Group Stock Performance

NYSE MD opened at $17.59 on Monday. Pediatrix Medical Group, Inc. has a 1-year low of $11.84 and a 1-year high of $18.22. The company has a market capitalization of $1.53 billion, a P/E ratio of 13.63 and a beta of 1.26. The business has a 50 day moving average price of $16.73 and a 200 day moving average price of $14.68. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The firm had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. During the same period last year, the business posted $0.34 EPS. Pediatrix Medical Group’s quarterly revenue was down 7.1% on a year-over-year basis. Sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.